IGC Pharma, Inc.IGCNYSE
Loading
ROE: Returns DecliningContracting
Percentile Rank14
Studio
Year-over-Year Change

Return on equity

Latest
-112.50%
↓ 99% vs avg
Percentile
P14
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
-56.51%
Historical baseline
PeriodValueYoY Change
2025-112.50%+36.6%
2024-177.57%-130.1%
2023-77.16%-22.8%
2022-62.85%-134.0%
2021-26.86%+2.6%
2020-27.57%-125.9%
2019-12.20%+44.9%
2018-22.15%+12.7%
2017-25.37%-21.8%
2016-20.84%-